Skip to main content
Equibles

PASW · Ping An Biomedical Co., Ltd. · Financials

Track PASW — free

Use PASW with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PASW.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.13 +0.04 (+45.65%) At close · Oct 22
Rebalance outlook locked
Market Cap
$11.51M
Shares
125.12M
Volume · Oct 22 7.39M Avg daily vol (3M) 6.32M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Diluted EPS
-$4.00
FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023
USD/shares -$4.00 — —
USD/shares -$4.00 — —
shares 461.99K 450K 450K
shares 461.99K 450K 450K
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2024: 9.93M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Operating lease liabilities 2026-03-31 CNY 272,911 6-K filed 2026-09-11
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
CNY 272,911
Operating lease liabilities 2026-03-31 USD 39,564 6-K filed 2026-09-11
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 39,564
Short-term borrowings 2026-03-31 CNY 10,000,000 6-K filed 2026-09-11
Short-term borrowings 2026-03-31 USD 1,449,696 6-K filed 2026-09-11
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Textile Manufacturing median 0.35×
EV/EBIT
—
P/E (TTM)
—

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (CNY)

Component FY2025 FY2024 FY2023
Sales of Yarns 32,421,473 83,269,024 77,040,009
Sales of Finished Garments 1,726,463 4,353,371 5,523,742
Key facts CIK 1897532 CUSIP G5880S113 Visit website Investor relations